The role of patient-reported outcome measures in the continuum of cancer clinical care
- DHV-NET
- May 12, 2022
- 1 min read
Updated: May 18, 2022
Highlights
•
This ESMO Guideline provides key recommendations on the role of PROMs during the care of patients with cancer.
•
It covers the use of PROMs in patients with cancer from the start of active treatment during follow-up and at the end of life.
•
Recommendations are based on available scientific evidence and the authors’ collective expert consensus.
•
Authorship includes a multidisciplinary group of experts from Europe, North America, Asia & Australia.
Keywords
PROs
PROMs
clinical practice
cancer
PROM implementation